CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study Modifiable lifestyle factors and heart failure: A Mendelian randomization study Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study Coronary plaque redistribution after stent implantation is determined by lipid composition: A NIRS-IVUS analysis Heart Failure and Atrial Fibrillation, Like Fire and Fury

ConsensusVolume 72, Issue 18, October 2018

JOURNAL:J Am Coll Cardiol. Article Link

Fourth Universal Definition of Myocardial Infarction (2018)

Thygesen K, Alpert JS, Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Keywords: Cardiac procedural myocardial injury; Cardiac troponin; Expert Consensus Document; High sensitivity cardiac troponin; Myocardial infarction; Myocardial infarction with non-obstructive coronary arteries (MINOCA); Myocardial injury; Prior myocardial infarction; Re-infarction; Recurrent myocardial infarction; Silent myocardial infarction; Takotsubo syndrome; Type 1 MI; Type 2 MI; Type 3 MI; Type 4a MI; Type 4b MI; Type 4c MI; Type 5 MI

FULL TEXT PDF